4//SEC Filing
Yi Sang 4
Accession 0001062993-25-002917
CIK 0001136869other
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 6:03 PM ET
Size
9.5 KB
Accession
0001062993-25-002917
Insider Transaction Report
Form 4
Yi Sang
Group President, Asia Pacific
Transactions
- Exercise/Conversion
Common Stock
2025-02-18+11,138→ 16,676 total - Award
Restricted Stock Units
2025-02-14+11,138→ 11,138 totalFrom: 2025-02-18Exp: 2025-02-18→ Common Stock (11,138 underlying) - Exercise/Conversion
Restricted Stock Units
2025-02-18−11,138→ 0 totalFrom: 2025-02-18Exp: 2025-02-18→ Common Stock (11,138 underlying)
Footnotes (3)
- [F1]Includes 216 shares acquired under the Employee Stock Purchase Plan and pursuant to dividend reinvestment through February 18, 2025.
- [F2]Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of Zimmer Biomet Holdings, Inc. (the "Company").
- [F3]On February 18, 2022, the reporting person was granted performance-based RSUs, with the number of RSUs earned to be determined based on the extent to which certain performance conditions were met for a performance period of 2022 - 2024. As determined on February 14, 2025, based on actual performance, the reporting person earned 11,138 RSUs, which vested on February 18, 2025
Issuer
ZIMMER BIOMET HOLDINGS, INC.
CIK 0001136869
Entity typeother
Related Parties
1- filerCIK 0001635943
Filing Metadata
- Form type
- 4
- Filed
- Feb 18, 7:00 PM ET
- Accepted
- Feb 19, 6:03 PM ET
- Size
- 9.5 KB